Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06405945

Cervical Cancer Susceptible Population Classification

Sponsor: Anhui Provincial Hospital

View on ClinicalTrials.gov

Summary

Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervical cancer. However, many reports lack clarity, consistency, and validation. In this comprehensive study, we will analyze the genomic risk factors associated with cervical cancer, classify individuals into different risk categories, and explore potential biomarkers and therapeutics.

Official title: Evalutaion of the SNPs Test in Average Cervical Cancer Screening Episode

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

10000

Start Date

2024-05-01

Completion Date

2036-06

Last Updated

2024-05-09

Healthy Volunteers

Yes

Interventions

GENETIC

PCR and sequence

sequence the mutatation SNPs

Locations (1)

The First Affiliated Hospital of USTC

Hefei, Anhui, China